AGL
agilon health, inc. (AGL) Business Model Analysis (2026)
Overall Score
Revenue Quality
Revenue quality is weak, with a near-zero gross margin (0.0014%) and negative net margin (-4.24%).
Asset turnover is high at 3.72x, but it is not translating into positive profitability.
Profitability
Operating margin remains negative at -4.48% and EBITDA margin at -3.95%.
Returns are deeply negative, including ROE of -119.35% and ROIC of -90.22%.
Cash Generation
Operating cash flow is negative, with OCF margin at -1.22% and free cash flow margin at -4.24%.
Free cash flow remains negative at -$104.5M, and FCF yield is -6.7%.
Balance Sheet
Liquidity is acceptable with a current ratio of 1.08x and quick ratio of 1.08x.
Leverage appears manageable, with debt-to-equity at 0.15x and net debt to EBITDA at 0.32x.
Efficiency
Working capital turnover is very high at 76.37x, indicating efficient use of capital.
The cash conversion cycle is 48.4 days, driven by 65.3 days of receivables and 17.0 days of payables.
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on agilon health, inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

